Share on

Global Cell Fractionation Market (Cell Lysis Market) Size, Share, Trends, COVID-19 Impact & Growth Analysis Report – Segmented By Product, Type Of Cell, End User & Region – Industry Forecast (2022 to 2027)

Published: January, 2022
ID: 2538
Pages: 175
Formats: report pdf report excel report power bi report ppt

Global Cell Fractionation Market Size (2022 to 2027)

The size of the global cell fractionation market is estimated to be growing at a CAGR of 10.50% during the forecast period. The size of the market is predicted to be worth USD 5.83 billion by 2027 from USD 3.54 billion in 2022.

Cell fractionation, also known as cell lysis, is a process of separating cellular components while preserving the individual functions of each component. 


Growing investments and support from the governments for research, YOY rise in the biotechnology and biopharmaceutical industries, YOY growth in of high prevalence of various diseases, and a growing focus on precision medicine are contributing to the cell fractionation market growth.

Due to increased government spending in most countries and the growing aging population, the cell fractionation market is expected to grow. Researchers use disruptive cells to investigate the morphology and structure of organelles and produce novel cell therapies and other cell-based treatments. Due to the significance of cell-based science, several government agencies have expanded their funding to expand such studies. As a result, many government agencies have offered financial assistance in investments and funds. Moreover, there is a massive increase in infectious diseases in the present situation, propelling the market's growth rate. 

Emerging economies are expected to offer growth opportunities for cell lysis/cell fractionation market participants.

The primary causes are the rising prevalence of chronic diseases, scientific technology developments, and supportive regulation in developing countries for cell-based research. Mammalian cells are the most widely fractionated cell types, owing to increased investments in cell-based science by businesses and governments and the rising prevalence of diseases such as HIV/AIDS and cancer. As a result, key industry players are expanding their presence in emerging markets such as China by developing new facilities and R&D and innovation centers. In addition, some of the major players, such as Thermo Fisher Scientific Inc. (US) and Merck KGaA (Germany), have implemented numerous growth strategies, such as mergers and acquisitions, new product releases, extensions, alliances, joint ventures, collaborations, and others, to improve their position in this market in the future.


High expenditure and costs associated with cell-based research are one of the key factors hampering the cell fractionation market growth.

Cell-based research providers or public servicers should spend high expenditures. The lack of skilled personnel also limits the market's growth rate. The shortage of experienced professionals is a significant restraint in the Cell Fractionation market. Moreover, the survival of new entrants also leads to restraint in the Cell Fractionation market. 

Impact of Covid-19 on the global cell fractionation market:

The cell fractionation market is affected by COVID-19 in many ways, especially economically. COVID-19 impacted the cell fractionation market in financial growth. Moreover, the supply chain of manufactured products is affected by the COVID-19 pandemic. Therefore, the cell fractionation market will regain the loss during the pandemic. Therefore, the cell fractionation market will be on track in the upcoming years.




Market Size Available

2021 to 2027

Base Year


Forecast Period

2022 to 2027

Segments Covered

By Product, Cell Type, End-User, Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis; DROC; PESTLE Analysis; Porter's Five Forces Analysis, Competitive Landscape, Analyst Overview of Investment Opportunities

Regions Covered

North America, Europe, APAC, Latin America, Middle East & Africa


This research report has segmented and sub-segmented the global cell fractionation market based on the product, cell type, end-user, and region.

Cell Fractionation Market - By Product:

  • Consumables
  • Reagents
    • Enzymes
    • Detergent Solutions
  • Beads
  • Disposables
  • Instruments
    • Sonicator
    • Homogenizer

By product, the consumables segment dominated the cell fractionation market in 2021.

The reagents segment is anticipated to account for a substantial global market share during the forecast period. On the other hand, enzymes are most frequently used for chemical cell disruption.

The sonicator segment is expected to grow at a healthy CAGR during the forecast period owing to the growing usage of cell lysis. However, the high cost of sonicators is limiting the growth rate of this segment.  

Cell Fractionation Market – By Cell Type:

  • Microbial
  • Mammalian

Based on cell type, the mammalian segment was the leader and accounted for a significant market share in 2021, owing to rising investments by governments and companies for cell-based research. In addition, the rising prevalence of diseases such as cancer and HIV/AIDS urges a demand for advanced treatment options and the development of cell therapies. As a result, it increases the market growth of mammalian and microbial cells.

Cell Fractionation Market – By End User:

  • Research Laboratories
  • Biopharmaceutical
  • Biotechnology Companies

Based on the end-user, the Research Laboratories segment accounts for the largest share of the end-user segment in the cell fractionation market. There are many attributing factors in the research laboratories and institutes segment. Some of the contributing factors are the increment in the prevalence of diseases and the rise of government investments. 

Cell Fractionation Market – By Region:

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa

Geographically, North America dominated the cell fractionation market with the highest share in 2021 because of advancements in biotechnology and commercialization. In addition, factors such as the favorable rise of the old citizen population and the surge of government funds are majorly propelling the market's growth rate in this region.

Asia Pacific is anticipated to hit the highest CAGR in the coming years. The Asia-Pacific region has attributing factors like the presence of strong key players in countries like China and India and the rise in the growth of the aging population. On the other hand, Europe has been recorded as the strongest contender in the cell fractionation market. The European region is also compressing advantageous factors such as improved advanced technology. 


Some of the prominent companies leading the global cell fractionation market profiled in this report are Beckman Coulter, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Cell Signaling Technology, Inc., F. Hoffman-La Roche AG, Merck KGaA, Miltenyi Biotec, QIAGEN N., Qsonica and Thermo Fisher Scientific Inc.


  • In 2020, Thermo Fisher Scientific teamed up with Northeastern University to promote research in precision medicine, monoclonal antibodies, and gene and cell therapies around the biopharmaceutical industry.
  • In 2020, Danaher Corporation purchased the biopharma division from GE Company's life science unit. Danaher is a leading research and technology innovator to assist consumers in overcoming challenging problems and strengthening the global quality of living. Its world-class brands hold leading positions in the competitive and appealing healthcare, environmental, and applied end-markets.
  • In March 2020, the Canadian Government spent approximately USD 7.0 million on stem cell science in Canada under the Stem CNetwork'srk's competitive research funding scheme.
  • In 2019, the Canadian Minister of Science and Sport reported USD 22.7 million in funding from Genome Canada and USD 33.4 million from provincial governments to support 36 research projects. The programs cover various topics, including medicine, nutrition, natural resources, and the atmosphere.

Please wait. . . . Your request is being processed


How much was the global cell fractionation market worth in 2021?

The global cell fractionation market size was worth USD 3.2 billion in 2021.

What is the CAGR of the cell lysis market?

The global cell lysis market is expected to grow at a CAGR of 10.5% from 2022 to 2027.

Which region led the cell fractionation market in 2021?

The North American region was the largest region in the global cell fractionation market in 2021.

Which are the companies playing a key role in the global cell fractionation market?

Beckman Coulter, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Cell Signaling Technology, Inc., F. Hoffman-La Roche AG, Merck KGaA, Miltenyi Biotec, QIAGEN N., Qsonica and Thermo Fisher Scientific Inc. are a few of the promising players in the cell fractionation market.

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2500

Didn’t find what you’re looking for?

Need something within your budget?


Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us:

Click for Request Sample